Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 USD | +2.70% | -0.87% | +4.59% |
Financials (USD)
Sales 2024 * | 17.54M | Sales 2025 * | 14.63M | Capitalization | 215M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -25M | EV / Sales 2024 * | 12.3 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 14.7 x |
P/E ratio 2024 * |
-10.1
x | P/E ratio 2025 * |
-9.19
x | Employees | 72 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.87% |
Latest transcript on Lineage Cell Therapeutics, Inc.
1 day | +2.70% | ||
1 week | -0.87% | ||
Current month | -22.97% | ||
1 month | -12.98% | ||
3 months | +3.64% | ||
6 months | -0.87% | ||
Current year | +4.59% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 52 | 18-09-16 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 22-11-13 |
Chief Operating Officer | - | 09-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 09-06-30 |
Brian Culley
CEO | Chief Executive Officer | 52 | 18-09-16 |
Director/Board Member | 66 | 14-04-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.14 | +2.70% | 313,340 |
24-04-25 | 1.11 | +0.91% | 359,695 |
24-04-24 | 1.1 | -3.51% | 747,332 |
24-04-23 | 1.14 | 0.00% | 333,219 |
24-04-22 | 1.14 | -0.87% | 429,952 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.59% | 215M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- LCTX Stock